Cochrane Evidence Synthesis and Methods ►

COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To synthesise the evidence for benefits and harms of SARS-CoV-2 vaccination for people with autoimmune rheumatic diseases on immunomodulatory therapies.

This is a protocol.

Health topics:

Infectious disease > COVID-19

Insurance medicine > Sick Leave > Musculoskeletal conditions

Published:

14 June 2021

Authors:

Whittle SL, Hazlewood GS, Robinson P, Johnston RV, Leder K, Glennon V, Avery JC, Grobler L, Buchbinder R

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Whittle SL, Hazlewood GS, Robinson P, Johnston RV, Leder K, Glennon V, Avery JC, Grobler L, Buchbinder R. COVID-19 vaccination for people with autoimmune inflammatory rheumatic diseases on immunomodulatory therapies (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 6. Art. No.: CD014991. DOI: 10.1002/14651858.CD014991.